Maria Elisa Mancuso on WFH Global Forum: A New Vision for Global Bleeding Disorder Care
Maria Elisa Mancuso, Senior Hematology Consultant at Humanitas Research Hospital, shared on LinkedIn:
”On November 13 and 14, 2025, I had the great opportunity to attend the WFH Global Forum in Montreal, Canada.
It was a unique meeting where high-level science, everyday clinical management, and social programs were presented as parts of a tightly interlinked network of competence and knowledge, providing a solid foundation for the path toward improved care for bleeding disorders.
I had the privilege of being part of the organizing committee, and I feel proud of the final outcome. Thanks to all the colleagues and experts who agreed to be part of this effort.
Discussions ranged from safety (and the need for continuous surveillance) to gene editing, always keeping in mind that nobody should be left behind.
We therefore addressed women and girls with bleeding disorders, how to apply what we have learned from hemophilia to VWD (including prophylaxis for all who bleed), and the possibility of using novel therapies such as rebalancing agents in other rare bleeding disorders.
It was a thought-provoking meeting where not all answers were available, but there was a clear, shared commitment to improving patient care.”
Keep up with Hemostasis Today.
-
Jan 6, 2026, 08:49Dr Abdul Mannan: Patient Has CAPS with 7000 Platelets – Do You Anticoagulate?
-
Jan 6, 2026, 08:30Jean-Michel Dogné on The Aspirin Dosing after Trump’s Announcement
-
Jan 6, 2026, 08:24Davide Liborio Vetrano: Metabolic Dysregulation as the Core Signature of Multimorbidity
-
Jan 6, 2026, 08:23Flora Peyvandi Shares Research: Non-Carrier Mothers of Hemophilia A Patients Often Have Other Gene Rearrangements
-
Jan 6, 2026, 08:16Classification of Anaemia: Three Main Ways by Samwel Mikaye
-
Jan 6, 2026, 08:16Maxime Dely: Why Centrifugation is the “Invisible Core” and Critical Lever in Blood Component Processing
-
Jan 6, 2026, 08:15Angela Beltrame Joins Versiti Blood Research Institute
-
Jan 6, 2026, 08:13Wolfgang Miesbach on FRONTIER2 Data: Mim8 Prophylaxis Achieves a Median ABR of Zero in Hemophilia A
-
Jan 6, 2026, 08:12Aravind Palraj: 5 Common Mistakes in Interpreting Autoimmune Labs